EP Patent

EP3435985A1 — Granulate formulation of 5-methy!-1-pheny!-2(1h)-pyridone and method of making the same

Assigned to F Hoffmann La Roche AG · Expires 2019-02-06 · 7y expired

What this patent protects

The disclosure relates to granulate formulations of pirfenidone and methods of making such formulations.

USPTO Abstract

The disclosure relates to granulate formulations of pirfenidone and methods of making such formulations.

Drugs covered by this patent

Patent Metadata

Patent number: EP3435985A1
Jurisdiction: EP
Classification: —
Expires: 2019-02-06
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.